| Product Name | MF | CAS | Details |
|---|
| 4-Chloro-6-(1H-imidazol-1-yl)-2-methylpyrimidine | C8H7ClN4 | 1250182-02-5 | Details |
| Cat IgM | Details |
| 2-(2,2-dimethylpropanoyl)-3-((2-bromo-4,6-dimethylphenyl)amino)prop-2-enenitrile | C16H19BrN2O | 1025270-12-5 | Details |
| Elastase 1 Blocking Peptide (Pancreatic) | Details |
| 2-(Azetidin-2-yl)propan-2-ol hydrochloride | C6H14ClNO | 1824166-46-2 | Details |
| 4-(2-Nitrophenyl)thiazol-2-amine | C9H7N3O2S | 90323-06-1 | Details |
| N,N'-Dimethyl-trans-1,2-cyclohexanediamine | C8H18N2 | 67579-81-1 | Details |
| 2-Acetamido-6-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-2-deoxy-D-galactopyranose | C16H28N2O11 | 452316-31-3 | Details |
| Ondansetron Related Compound D | C14H13NO | 99614-64-9 | Details |
| Isoxyl | C23H32N2O2S | 910-86-1 | Details |
| 4-Propanoylbenzonitrile | C10H9NO | 52129-98-3 | Details |
| 6-amino-2-azaspiro[3.3]heptane-6-carboxylic acid dihydrochloride | C7H13ClN2O2 | 1170461-72-9 | Details |
| RBM34 Blocking Peptide | Details |
| POU5F1 antibody | Details |
| Salpriolactone | C15H14O3 | 132278-72-9 | Details |
| 2'-Deoxy-2',2'-difluorocytidine 5'-triphosphate triethylammonium salt - Aqueous solution | C9H14F2N3O13P3 | 110988-86-8 | Details |
| 1-(Cyclopentylmethyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid | C10H15N3O2 | 1275179-64-0 | Details |
| (1,3-Dimethylpiperidin-3-yl)methanol | C8H17NO | 915925-11-0 | Details |
| 5-cyclopropyl-1,3-oxazole-4-carboxylic acid | C7H7NO3 | 917828-31-0 | Details |
| alpha,alpha,alpha-Trifluoro-o-cresol | C7H5F3O | 444-30-4 | Details |
| 4-Nitro benzenebutanoic acid | C10H11NO4 | 5600-62-4 | Details |
| 1-Methyl-4-(piperidin-4-yloxy)piperidine dihydrochloride | C11H23ClN2O | 635699-23-9 | Details |
| 3,4-Dichloro-5-hydroxyfuran-2(5H)-one | C4H2Cl2O3 | 766-40-5 | Details |
| 1-Naphthoyl chloride | C11H7ClO | 879-18-5 | Details |
| (R,S)-Nornicotine | C9H12N2 | 5746-86-1 | Details |
| Glucurono-xylomannan polysaccharide from Tremella fuciformis | 76082-65-0 | Details |
| GDC-0575 dihydrochloride | C16H21BrClN5O | 1657014-42-0 | Details |
| Fluorooxindole | C8H6FNO | 56341-41-4 | Details |
| (2R)-1-(1-Ethyl-2,3-dihydro-1H-indol-5-yl)propan-2-amine dihydrochloride | 2287248-19-3 | Details |
| 2-(2-Methyl-1H-1,3-benzodiazol-1-yl)acetic acid hydrochloride | C10H11ClN2O2 | 1177310-33-6 | Details |
| 3-Azidopropanoate-N-hydroxysuccinimide ester | C7H8N4O4 | 850180-76-6 | Details |
| H-ETLDPSAPK-OH | Details |
| Lacto-N-neotetraosa-APD-HSA | Details |
| 3,5-Dichlorophenylhydrazine hydrochloride | C6H7Cl3N2 | 63352-99-8 | Details |
| SLC10A4 Blocking Peptide | Details |
| Medetomidine | C13H16N2 | 86347-14-0 | Details |
| 2,3,5-Trichloroquinoxaline | C8H3Cl3N2 | 2958-86-3 | Details |
| Methyl 4-(3-iodopyridin-4-yl)piperazine-1-carboxylate | C11H14IN3O2 | 1803566-55-3 | Details |
| PLGA | C5H10O6 | 34346-01-5 | Details |
| 2’-Deoxy-N4-dimethylcytidine | C11H17N3O4 | 53213-03-9 | Details |
| 4-(3,3-Dimethylpiperidin-1-yl)butan-2-one | C11H21NO | 1343895-87-3 | Details |
| SK33 | C20H13F9N2O3 | 1928724-23-5 | Details |
| 2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexene-1-carboxaldehyde | C15H17ClO | 1228837-05-5 | Details |
| Human IL1RA ELISA Kit | Details |
| Methyl 5-formyl-3-methyl-1H-pyrrole-2-carboxylate | C8H9NO3 | 1554586-97-8 | Details |
| 3-Cyclopentylpropanal | C8H14O | 6053-89-0 | Details |
| MMP17 antibody | Details |
| 1-[4-(Trifluoromethyl)phenyl]pyrrolidin-3-amine | C11H13F3N2 | 1001755-31-2 | Details |
| AZD7594 | C32H32F2N4O6 | 1196509-60-0 | Details |
| 1-(3-Bromophenyl)-1H-pyrazole-3-carboxylic acid | C10H7BrN2O2 | 1152557-01-1 | Details |
| Chloromethyl methyl carbonate | C3H5ClO3 | 40510-81-4 | Details |
| ZIP7 antibody | Details |
| 1,1-Dimethylsilolan-3-amine hydrochloride | C6H16ClNSi | 2109019-09-0 | Details |
| Histamine release ELISA kit | Details |
| 1-(4-Methyl-2,5-dioxoimidazolidin-4-yl)urea | C5H8N4O3 | 10045-73-5 | Details |
| 1-(3-Aminopropoxy)-2,3,5-trimethylbenzene hydrochloride | C12H20ClNO | 1177299-18-1 | Details |
| [Gln11]-beta-Amyloid (1-28) | C145H210N42O45 | 106686-61-7 | Details |
| 6,6-Dimethyl-3-(morpholine-4-carbonyl)-4,5,6,7-tetrahydro-1-benzothiophen-2-amine | C15H22N2O2S | 1384594-76-6 | Details |
| Methyl 5-(3,4-dichlorophenyl)-1H-pyrazole-3-carboxylate | C11H8Cl2N2O2 | 192702-24-2 | Details |
| 4,7-Dihydroxy-1,10-phenanthroline | C12H8N2O2 | 3922-40-5 | Details |
| CMVpp65 - 130 (ANDIYRIFAELEGVW) | Details |
| Ethyl 3-cyclohexyl-2-fluoroprop-2-enoate | C11H17FO2 | 1254810-12-2 | Details |
| FCRLA Blocking Peptide | Details |
| Methyl 3-chloro-1,2-benzoxazole-5-carboxylate | C9H6ClNO3 | 16302-66-2 | Details |
| EFEMP2 Blocking Peptide | Details |
| Ethyl(quinolin-2-ylmethyl)amine dihydrochloride | C12H16Cl2N2 | 1269151-18-9 | Details |
| SIVmac239 - 87 | C59H97N17O23S2 | Details |
| 5-(2-Phenylethyl)imidazolidine-2,4-dione | C11H12N2O2 | 120379-81-9 | Details |
| 2-Bromo-3-chlorobenzyl Alcohol | C7H6BrClO | 1232407-29-2 | Details |
| 3-O-Benzyl-5,6-di-O-acetyl-1,2-O-isoproylidene-a-D-glucofuranose | C20H26O8 | 18006-25-2 | Details |
| 5-Methyl-5H,6H,7H,8H-imidazo[1,2-a]pyridine-3-carboxylic acid hydrochloride | C9H13ClN2O2 | 1955539-69-1 | Details |
| Norescitalopram antibody | Details |
| 3-Nitro-4-(pyrimidin-2-ylsulfanyl)benzaldehyde | C11H7N3O3S | 663206-26-6 | Details |
| FAM92B Blocking Peptide | Details |
| 1-Methylindoline-5-carbaldehyde | C10H11NO | 60082-02-2 | Details |
| Cyclooctanecarbonitrile | C9H15N | 40636-30-4 | Details |
| ethyl 4-((phenylamino)thioxomethyl)piperazinecarboxylate | C14H19N3O2S | 332033-11-1 | Details |
| [1-(Trifluoromethyl)cyclobutyl]methanamine | C6H10F3N | 1522712-18-0 | Details |
| 2,5-Dihydroxybenzohydrazide | C7H8N2O3 | 15791-90-9 | Details |
| (1-Cyanocyclohexyl)methanesulfonamide | C8H14N2O2S | 1461706-15-9 | Details |
| tert-Butyl N-[3-(3-aminopropoxy)propyl]carbamate | C11H24N2O3 | 848419-01-2 | Details |
| FXYD1 Blocking Peptide | Details |
| tert-Butyl 4-(iodomethyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate | C11H20INO3 | 1087789-13-6 | Details |
| {1-[(4-Fluorophenyl)methyl]cyclopropyl}methanamine | C11H14FN | 1368784-01-3 | Details |
| SETD3 antibody | Details |
| 1-(2-Chlorophenyl)-2-(4-fluorophenyl)ethan-1-one | C14H10ClFO | 137101-74-7 | Details |
| HDAC1 Antibody (FITC) | Details |
| ORM protein | Details |
| 3-Amino-6-chloro-3,4-dihydro-2H-1-benzopyran-4-one hydrochloride | C9H9Cl2NO2 | 20811-81-8 | Details |
| Notch 3 homolog antibody | Details |
| 6-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3-amine | C7H5F3N4 | 1180519-29-2 | Details |
| tert-Butyl N-({2-oxo-6-oxaspiro[3.4]octan-7-yl}methyl)carbamate | C13H21NO4 | 2287280-65-1 | Details |
| 1-Propyl-1H-1,2,3-triazole-4-carbaldehyde | C6H9N3O | 1495240-18-0 | Details |
| Normal Pig Serum | Details |
| 2-Methyl-2-(1,3-thiazol-4-yl)propanoic acid | C7H9NO2S | 1517473-55-0 | Details |
| 2-Chloro-5-methanesulfonylbenzene-1-sulfonyl chloride | C7H6Cl2O4S2 | 90084-62-1 | Details |
| tert-Butyl N-(2-hydroxyethyl)-N-(piperidin-4-yl)carbamate | C12H24N2O3 | 367282-50-6 | Details |
| (2-Chloro-4-methylphenyl)thiourea | C8H9ClN2S | 57005-14-8 | Details |
| 3-(1,3-Dioxaindane-5-amido)thiophene-2-carboxylic acid | C13H9NO5S | 926192-73-6 | Details |
| H-DSPVLIDFFEDTER^-OH | Details |
| Product Total： Product Page： | ||||
| 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 | ||||